Study of switching from sucroferric oxyhydroxide chewables to microtablets–A multicenter retrospective observational study–

Abstract

Hyperphosphatemia is common and associated with a worse prognosis in hemodialysis patients. Improved adherence to phosphate binders could lead to better control of phosphate levels in hemodialysis patients. We performed a survey and evaluated the changes in clinical parameters seen in hemodialysis patients that were switched from sucroferric oxyhydroxide (SO) chewables to microtablets. The results of the survey suggested that microtablets improved adherence. Stable clinical parameters, including bone mineral and blood iron and hemoglobin levels, were observed after the switch to microtablets. Switching from SO chewables to microtablets might contribute to better phosphate management in hemodialysis patients.